Company: JUNS
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001493152-25-018523
Chunk: 72

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 72
---
 dates to allow additional time to solicit additional proxies in favor of a proposal or to establish a quorum.

Vote Required

The affirmative vote of a majority of the shares (by voting power) present in person at the virtual Annual Meeting or represented by proxy and entitled to vote at the virtual Annual Meeting is required to approve any adjournments of the virtual Annual Meeting to permit further solicitation of proxies in the event that there are insufficient votes to approve a proposal or to establish a quorum.

Recommendation of our Board

OUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” ADJOURNMENT.

| -43- |

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</div>

The following table sets forth information regarding the beneficial ownership of our common stock as of October 15, 2025 by:

| ● | each                                                                                       
 person known by us to be the beneficial owner of more than 5% of our outstanding shares of 
 common stock;                                                                              |
| ● | each                                                                                       
 of our executive officers and directors that beneficially owns shares of our common stock; 
 and                                                                                        |
| ● | all                                                                                        
 our executive officers and directors as a group.                                           |

In the table below, percentage ownership is based on 35,920,483 shares of our common stock issued and outstanding as of October 15, 2025. Unless otherwise noted below, the address for each beneficial owner listed on the table is c/o Jupiter Neurosciences, Inc., 1001 North US Hwy 1, Suite 504, Jupiter, FL 33477. We have determined beneficial ownership in accordance with the rules of the SEC. We believe, based on the information furnished to us, that the persons and entities named in the tables below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws.

| Name                                 
 and Address of Beneficial Owner      |     | Amount                                        
 and Nature of Shares Beneficial Ownership (1) |            |     |     | Percentage  
 of Class(%) |      |
| Executive                            
 Officers and Directors:              |     |                                               |            |     |     |             |      |
| Christer Rosén                       |     |                                               | 13,080,566 |  -2 |     |             | 36.4 |
| Marshall Hayward, Ph.D               |     |                                               |